stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / AMGN / Free Cash Flow

Amgen Inc. Free Cash Flow 2007–2025

Amgen Inc. (AMGN) annual free cash flow by fiscal year, computed from SEC filings. Compound growth +3.8%/yr over 18 years.

Fiscal yearFree Cash FlowChange (YoY)
FY 2025$8.10B-22.1%
FY 2024$10.39B+41.2%
FY 2023$7.36B-16.2%
FY 2022$8.79B+4.8%
FY 2021$8.38B-15.2%
FY 2020$9.89B+15.9%
FY 2019$8.53B-19.2%
FY 2018$10.56B+0.4%
FY 2017$10.51B+9.3%
FY 2016$9.62B+5.2%
FY 2015$9.14B+11.0%
FY 2014$8.23B+47.1%
FY 2013$5.60B+7.8%
FY 2012$5.19B+14.1%
FY 2011$4.55B-12.6%
FY 2010$5.21B-10.3%
FY 2009$5.81B+9.2%
FY 2008$5.32B+28.6%
FY 2007$4.13B

Source: Amgen Inc. SEC filings — cash flow statement (10-K). Refreshed nightly.

See the full picture for Amgen Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Amgen Inc. — frequently asked questions

What is Amgen Inc.'s free cash flow?

Amgen Inc. (AMGN) reported free cash flow of $8.10B for fiscal year 2025, per its SEC filings.

How has Amgen Inc.'s free cash flow changed over time?

Between fiscal 2007 and 2025, AMGN's free cash flow grew at roughly 3.8% per year (compound annual rate), from $4.13B to $8.10B.

Where does this data come from?

Figures are computed from Amgen Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.

More AMGN financial history

Full AMGN fundamentals page → · All 1,500+ companies →